Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Amends $25M Loan Pact

NEW YORK (GenomeWeb News) – Caliper Life Sciences has amended a loan agreement with Silicon Valley Bank that extends the maturity date of the credit facility to April 1, 2011 from the previous date of Nov. 30, 2010, according to a filing yesterday with the US Securities and Exchange Commission.

The amended agreement was signed last week and updates the loan pact that was initially signed in March of this year.

Under the agreement, Caliper may borrow up to $25 million in the form of revolving loan advances including up to $5 million in the form of letters of credit. Borrowings under the credit facility accrue interest equal to prime plus one percent if Caliper's unrestricted cash held at Silicon Valley Bank exceeds or is equal to $20 million, or prime plus 2 percent if it is below $20 million.

Caliper said that it utilizes cash from the credit facility for ongoing operations and working capital needs.

Earlier this week, Caliper said that it had sold its Xenogen Biosciences subsidiary to Taconic Farms for approximately $11 million.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more